Corvus Pharmaceuticals, Inc.

NASDAQ:CRVS

3.22 (USD) • At close April 21, 2025
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q4
Omzet 00000.246000000000000000000000000000000000000
Kosten van de omzet 000.0210.0230.0280.030.0360.0570.09400.0920.0870.0930.1080.1220.1370000000000000000000000000
Brutowinst 00-0.021-0.0230.218-0.03-0.036-0.057-0.0940-0.092-0.087-0.093-0.108-0.122-0.1370000000000000000000000000
Brutowinstmarge 00000.886000000000000000000000000000000000000
Onderzoek- en ontwikkelingskosten 5.9745.2224.1144.0753.9993.9653.9684.5944.0810.3654.9235.14.7886.9919.1068.237.1916.6197.85710.1638.928.99610.649.4198.3948.3749.71512.1039.68810.73312.38613.4979.1317.7077.1195.3974.9092.5142.0051.9240.041
Algemene en administratieve kosten 2.1312.0331.8212.1781.6521.5951.6541.981.5862.1082.092.3132.0222.0562.1843.2532.6883.2262.913.1062.522.5172.9562.8862.7772.7752.5432.5412.5012.2112.7882.722.1182.7691.7061.0291.1950.6060.3270.290.112
Verkoop- en marketingkosten 000-0.023-0.028000000000000000000000000000000000000
Verkoop-, algemene en administratieve kosten 2.1312.0331.8212.1551.6241.5951.6541.981.5862.1082.092.3132.0222.0562.1843.2532.6883.2262.913.1062.522.5172.9562.8862.7772.7752.5432.5412.5012.2112.7882.722.1182.7691.7061.0291.1950.6060.3270.290.112
Overige kosten 00000.022000.0560.1480.1470.1460.1460.1410.0940037.459000000000000000000000-17.90.30
Bedrijfskosten 8.1057.2555.9356.235.6235.565.6226.5745.66612.4737.0137.4136.819.04711.2911.4839.8799.84510.76713.26911.4411.51313.59612.30511.17111.14912.25814.64412.18912.94415.17416.21711.24910.4768.8256.4266.1043.122.3322.2140.154
Bedrijfsresultaat -8.105-7.255-5.935-6.253-5.651-5.56-5.622-6.574-5.666-12.473-7.013-7.413-6.81-9.047-11.29-11.483-9.879-9.845-10.767-13.269-11.44-11.513-13.596-12.305-11.171-11.149-12.258-14.644-12.189-12.944-15.174-16.217-11.249-10.476-8.825-6.426-6.104-3.12-2.332-2.214-0.154
Bedrijfsresultaat ratio 0000-22.972000000000000000000000000000000000000
Totaal overige inkomsten en kosten netto -4.008-32.9621.6730.552-1.002-0.44-0.881-1.299-4.15-2.358-1.35-0.884-2.426-1.626-0.462-0.09737.2260.0490.1560.3340.3930.5090.6180.6620.6620.6510.6270.3430.260.2270.1930.1810.1640.1790.180.0790.065-0.031-17.90.3010
Inkomen voor belasting -12.113-40.217-4.262-5.701-6.653-6-6.503-7.873-9.816-14.831-8.363-8.297-9.236-10.673-11.752-11.5827.347-9.796-10.611-12.935-11.047-11.004-12.978-11.643-10.509-10.498-11.631-14.301-11.929-12.717-14.981-16.036-11.086-10.297-8.645-6.347-6.039-3.151-20.232-1.913-0.154
Inkomen voor belasting ratio 0000-27.045000000000000000000000000000000000000
Belastingkosten 000-0.02-0.095-0.425-0.4030.9236.384-0.225-0.10.8840.008-1.604-0.001-0.003-0.143000-0.185-0.18600-0.18000-0.219000-0.18400017.600-0.0010
Nettowinst -12.113-40.217-4.262-5.701-6.653-6-6.503-8.796-16.2-14.831-8.263-9.181-9.236-10.673-11.752-11.5827.347-9.796-10.611-12.935-11.047-11.004-12.978-11.643-10.509-10.498-11.631-14.301-11.929-12.717-14.981-16.036-11.086-10.297-8.645-6.347-6.039-3.151-20.232-1.913-0.154
Nettowinstmarge 0000-27.045000000000000000000000000000000000000
WPA (Winst Per Aandeel) -0.2-0.6-0.071-0.12-0.14-0.12-0.14-0.19-0.35-0.32-0.18-0.2-0.2-0.24-0.28-0.340.92-0.33-0.36-0.44-0.38-0.37-0.44-0.4-0.36-0.36-0.4-0.63-0.58-0.62-0.73-0.79-0.55-0.51-0.43-5.39-0.68-0.15-0.99-0.094-0.49
Verwaterde WPA -0.2-0.6-0.071-0.12-0.14-0.12-0.14-0.19-0.35-0.32-0.18-0.2-0.2-0.24-0.28-0.340.92-0.33-0.36-0.44-0.38-0.37-0.44-0.4-0.36-0.36-0.4-0.63-0.58-0.62-0.73-0.79-0.55-0.51-0.43-5.39-0.68-0.15-0.99-0.094-0.49
EBITDA -8.085-7.234-5.912-6.23-5.601-5.53-5.586-6.461-5.424-12.473-7.013-7.413-9.143-10.565-11.168-11.346-9.737-9.698-10.608-13.085-11.255-11.327-13.41-12.119-10.991-10.921-12.038-14.425-11.97-12.733-14.966-16.013-11.065-10.317-8.681-6.3211.553-3.065-2.297-2.2130
EBITDA ratio 0000-22.768000000000000000000000000000000000000